A Chinese traditional medicine, Sho-saiko-to (Xiao-Chaihu-Tang), reduces the bioavailability of tolbutamide after oral administration in rats

被引:10
作者
Nishimura, N [1 ]
Naora, K [1 ]
Hirano, H [1 ]
Iwamoto, K [1 ]
机构
[1] Shimane Med Univ Hosp, Dept Pharm, Izumo, Shimane 6938501, Japan
来源
AMERICAN JOURNAL OF CHINESE MEDICINE | 1999年 / 27卷 / 3-4期
关键词
D O I
10.1142/S0192415X99000409
中图分类号
R [医药、卫生];
学科分类号
10 [医学];
摘要
The effects of Sho-saiko-to on the pharmacokinetics of tolbutamide were investigated in rats. After intravenous administration of tolbutamide (5 mg/kg), no significant change in the pharmacokinetics of tolbutamide was observed in both groups of single and multiple (7 days) pre-administration of Sho-saiko-to (500 mg/kg). In the study of single oral administration of tolbutamide (50 mg/kg), co-administration of Sho-saiko-to tended to accelerate the initial absorption rate of tolbutamide. The area under the plasma concentration-time curve of tolbutamide after oral administration was significantly reduced by Sho-saiko-to. Subsequently, a significant decrease was observed in the oral bioavailability of this drug when Sho-saiko-to was given concomitantly. These findings suggest that Sho-saiko-to reduces the bioavailability of tolbutamide after oral administration in rats, and that this change is not related to hepatic metabolism.
引用
收藏
页码:355 / 363
页数:9
相关论文
共 16 条
[1]
EFFECTS OF TRADITIONAL CHINESE MEDICINES (DAI-SAIKO-TO, SHO-SAIKO-TO AND HACHIMI-ZIO-GAN) ON SPONTANEOUSLY DIABETIC RAT (WBN KOB) WITH EXPERIMENTALLY INDUCED LIPID AND MINERAL DISORDERS [J].
GOTO, M ;
HAYASHI, M ;
TODOROKI, T ;
SEYAMA, Y ;
YAMASHITA, S .
FOLIA PHARMACOLOGICA JAPONICA, 1992, 100 (04) :353-358
[2]
DRUG INTERACTIONS WITH ORAL SULFONYLUREA HYPOGLYCEMIC DRUGS [J].
HANSEN, JM ;
CHRISTENSEN, LK .
DRUGS, 1977, 13 (01) :24-34
[3]
DIFFERENT EFFECTS OF TRADITIONAL CHINESE MEDICINES CONTAINING SIMILAR HERBAL CONSTITUENTS ON PREDNISOLONE PHARMACOKINETICS [J].
HOMMA, M ;
OKA, K ;
IKESHIMA, K ;
TAKAHASHI, N ;
NIITSUMA, T ;
FUKUDA, T ;
ITOH, H .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1995, 47 (08) :687-692
[4]
HOSOYA J, 1993, JPN J HOSP PHARM, V19, P203
[5]
Huang Yongping, 1997, Keio Journal of Medicine, V46, P132
[6]
Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis [J].
Ishizaki, T ;
Sasaki, F ;
Ameshima, S ;
Shiozaki, K ;
Takahashi, H ;
Abe, Y ;
Ito, S ;
Kuriyama, M ;
Nakai, T ;
Kitagawa, M .
EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (12) :2691-2696
[7]
CLINICAL-PHARMACOLOGY OF SULFONYLUREA HYPOGLYCEMIC AGENTS .2. [J].
JACKSON, JE ;
BRESSLER, R .
DRUGS, 1981, 22 (04) :295-320
[8]
SMALL INTESTINAL CYTOCHROMES-P450 [J].
KAMINSKY, LS ;
FASCO, MJ .
CRITICAL REVIEWS IN TOXICOLOGY, 1992, 21 (06) :407-422
[9]
Kase Y, 1997, BIOL PHARM BULL, V20, P1155, DOI 10.1248/bpb.20.1155
[10]
KIVISTO KT, 1992, EUR J CLIN PHARMACOL, V42, P675